Trump Administration Eyes Ibogaine Research For PTSD Treatment, Stock Jumps - Psyence Biomedical (NASDAQ:
Gilgamesh Withdraws Patent Fight Against Enveric After $1.2 Billion AbbVie Deal, CEO Says Key Drug Claims Now Uncontested - Enveric Biosciences (NASDAQ:ENVB)
Ações da Enveric Biosciences disparam após divulgação de novos dados sobre candidato a medicamento principal